ProLectin-I

N/A

Report date: 2025/03/20 09:54:20
NME

Base Information

Drug NameProLectin-I
Drug Alias Namegalectin inhibitor (Bioxytran)
ClassificationSmall molecules > Carbohydrate > Oligosaccharide
Mechanisms of ActionGalectins inhibitorsCoronavirus spike glycoprotein inhibitors
TargetsCoronavirus spike glycoproteinGalectins
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Idiopathic Pulmonary FibrosisInfluenza, Human
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesIndia
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBioXyTran Inc
China Registration ClassN/A

Develop Information

Active CompaniesPharmalectin India Private LimitedBioXyTran Inc
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)Idiopathic Pulmonary FibrosisInfluenza, Human
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A